IGF2BP2 overexpression in LSCC promotes the CDK6 mRNA stability and protein expression, thus increasing the expression of CDK6 and promoting LSCC cell proliferation and invasion in vitro and tumor growth in xenograft tumor models (64). Here, IGF2BP2 is linked to neoplasm.